Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Distinguishing Clear Cell Renal Cell Carcinoma, Retroperitoneal Paraganglioma, and Adrenal Cortical Lesions on Limited Biopsy Material: Utility of Immunohistochemical Markers

Distinguishing Clear Cell Renal Cell Carcinoma, Retroperitoneal Paraganglioma, and Adrenal... Downloaded from http://journals.lww.com/appliedimmunohist by BhDMf5ePHKbH4TTImqenVA5KvPVPZ0P5BEgU+IUTEfzO/GUWifn2IfwcEVVH9SSn on 06/10/2020 RESEARCH ARTICLE Distinguishing Clear Cell Renal Cell Carcinoma, Retroperitoneal Paraganglioma, and Adrenal Cortical Lesions on Limited Biopsy Material Utility of Immunohistochemical Markers James E. Lapinski, MD, Longwen Chen, MD, PhD, and Ming Zhou, MD, PhD enal cell carcinoma (RCC) accounts for 2% to 4% Abstract: Retroperitoneal recurrence of clear cell renal cell Rof all adult malignancies, but more than 90% of carcinoma (CCRCC) after surgical resection is often investi- malignancies involving the kidney in both males and gated by needle biopsy and frequently requires immunohisto- females. The most common histologic subtype of RCC is chemistry to distinguish from other lesions with similar clear cell RCC (CCRCC), accounting for 60% to 80% histology. This study explores the diagnostic utility of a panel of RCC cases. CCRCC is well known for its tendency to of immunohistochemical markers and emphasizes potential metastasize. Up to one-third of patients with localized pitfalls in dealing with this differential diagnosis. A tissue CCRCC will eventually develop local and distant recur- microarray with 1 mm tissue cores was constructed to include rence after surgical resection, after 10 years or more in 21 CCRCC, 19 adrenocortical lesions, and 15 retroperitoneal some http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Applied Immunohistochemistry & Molecular Morphology Wolters Kluwer Health

Distinguishing Clear Cell Renal Cell Carcinoma, Retroperitoneal Paraganglioma, and Adrenal Cortical Lesions on Limited Biopsy Material: Utility of Immunohistochemical Markers

Loading next page...
 
/lp/wolters-kluwer-health/distinguishing-clear-cell-renal-cell-carcinoma-retroperitoneal-550q6HY9CU

References

References for this paper are not available at this time. We will be adding them shortly, thank you for your patience.

Publisher
Wolters Kluwer Health
ISSN
1541-2016
DOI
10.1097/PAI.0b013e3181ddf7b9
Publisher site
See Article on Publisher Site

Abstract

Downloaded from http://journals.lww.com/appliedimmunohist by BhDMf5ePHKbH4TTImqenVA5KvPVPZ0P5BEgU+IUTEfzO/GUWifn2IfwcEVVH9SSn on 06/10/2020 RESEARCH ARTICLE Distinguishing Clear Cell Renal Cell Carcinoma, Retroperitoneal Paraganglioma, and Adrenal Cortical Lesions on Limited Biopsy Material Utility of Immunohistochemical Markers James E. Lapinski, MD, Longwen Chen, MD, PhD, and Ming Zhou, MD, PhD enal cell carcinoma (RCC) accounts for 2% to 4% Abstract: Retroperitoneal recurrence of clear cell renal cell Rof all adult malignancies, but more than 90% of carcinoma (CCRCC) after surgical resection is often investi- malignancies involving the kidney in both males and gated by needle biopsy and frequently requires immunohisto- females. The most common histologic subtype of RCC is chemistry to distinguish from other lesions with similar clear cell RCC (CCRCC), accounting for 60% to 80% histology. This study explores the diagnostic utility of a panel of RCC cases. CCRCC is well known for its tendency to of immunohistochemical markers and emphasizes potential metastasize. Up to one-third of patients with localized pitfalls in dealing with this differential diagnosis. A tissue CCRCC will eventually develop local and distant recur- microarray with 1 mm tissue cores was constructed to include rence after surgical resection, after 10 years or more in 21 CCRCC, 19 adrenocortical lesions, and 15 retroperitoneal some

Journal

Applied Immunohistochemistry & Molecular MorphologyWolters Kluwer Health

Published: Oct 1, 2010

There are no references for this article.